SynthesisFrontiers in oncology2026
Survival benefit and toxicity trade-offs of first-line chemoimmunotherapy in advanced gastric and gastroesophageal junction cancer: a meta-analysis of randomized trials.
Xiaoli Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.